Federal Circuit Clarifies Reach of “Artificial” Act of Patent Infringement

From Minding Your Business on January 3, 2024

Alvogen Continues IP Fight Over Cancer Drug Imbruvica

Siegmund Y. Gutman, David M. Hanna, Michelle M. Ovanesian and Gourdin W. Sirles are mentioned for representing Alvogen.

From Law360 on October 7, 2022

“Negative” Patent Claim Limitations—May They be Adequately Described by Omission?

From Proskauer in Life Sciences Blog on February 24, 2022

New York Broadens the Scope of Admissible Employee Statements

From Minding Your Business Blog on February 10, 2022

“About-Face” Representations to FDA Will Be Used Against You

From Proskauer in Life Sciences Blog on September 22, 2021

Update on Artificial Intelligence: Court Rules that AI Cannot Qualify As “Inventor”

From Proskauer in Life Sciences Blog on September 9, 2021

Supreme Court Rules that Inventors Can Contest the Validity of Patents After Assigning Them

on July 1, 2021

Beware the Privilege Waiver During Investor Due Diligence

From Minding Your Business Blog on November 2, 2020

Defendants in Vineyard Vines Trademark Dispute Hit with Liquidated Damages and Attorneys’ Fees

From New England IP Blog on December 21, 2018

Gun Trigger Patent Lawsuit Misfire Does Not Warrant “Exceptional Case” Finding

From New England IP Blog on October 29, 2018